SlideShare uma empresa Scribd logo
1 de 22
Baixar para ler offline
FACTORS AFFECTING
BIOTRANSFORMATION OF
DRUGS
PRESENTED BY:
HADIA ARSHAD
TYPES OF FACTORS
• Chemical
• Biological
• Altered Physiological
• Temporal
• Route of Drug Administration
• Enviornmental
Chemical Factors
1. Enzyme Induction
2. Enzyme Inhibition
Enzyme Induction
It is a process in which a drug induces or enhances
the expression of an enzyme.
Rifampicin If taken by female patients taking
contraceptives, causes decreased therapeutic effect, leading to
pregnancy.
Phenobarbitone If administered to patients taking warfarin, may
cause therapeutic failure, leading to increased bleeding
tendency.
Auto induction: The phenomenon in which a
drug induces metabolism of other drugs as well
as its own E.g. carbamazepine-antiepileptic.
Enzyme Inhibition
Decrease in the drug metabolizing ability of
enzymes. Competition for the active sites
takes place between the inhibitor and the
drugs. When enzyme inhibitor attaches,
less metabolism occurs. E.g.
 Sulfonamides decrease the metabolism of phenytoin so that its
blood levels become toxic.
 Cimetidine decreases the metabolism of propanolol leading to
enhanced bradycardia.
 Oral contraceptives inhibit metabolism of antipyrine.
Biological Factors
Age
Gender
Genetics
Race
Diet
AGE
In infants microsomal enzyme system is not fully
developed. The rate of metabolism is very low.
Care should be taken in administering drugs in
younger patients.
 Chloramphenicol does not have great efficacy in
infants. Toxic effects in the form of grey baby
syndrome might occur. The baby may be
cyanosed, hypothermic, flaccid and grey in color.
Shock and even death might occur if toxic levels
get accumulated.
 Diazepam may result in floppy baby syndrome in
which flaccidity of the baby is seen.
AGE
In elderly, most processes slow down
which leads to decreased metabolism.
Shrinkage of organs occurs as well
along with decreased liver functions
and decreased blood flow through the
liver. All these factors decrease the
metabolism.
The drug doses should be decreased in
the elderly
GENDER
Gender related differences in the rate of
metabolism are attributed to sex hormones and
are generally observed following puberty.
 Male have a higher BMR as compared to the
females, thus can metabolize drugs more
efficiently, e.g. salicylates and others might
include ethanol, propanolol, benzodiazepines.
 Women on oral contraceptives metabolize drugs
at a slower rate
GENETICS
Drugs behave differently in different individuals due to
genetic variations
Succinyl choline, which is a skeletal muscle relaxant, is metabolized
by pseudocholine esterase. Some people lack this enzyme, due to
which lack of metabolism of succinyl choline might occur. When
administered in those individuals, prolonged Apnea might result.
Different groups of populations might be classified as fast
metabolizers and poor metabolizers of drugs.
For drugs, like Isoniazid, fast acetylators as well as slow acetylators
are present. Fast acetylators cause rapid acetylation, while poor
metabolizers metabolize less. Hepatic acetyl transferrase catalyzes
acetylation. Slow acetylation might occur due to genetic
malformation leading to decreased production.
RACE/SPECIES
 Asians, Orientals, Blacks and Whites
might have different drug metabolizing
capacity. Examples include difference in
drug metabolizing capacity of certain
anti malarial.
 Eskimos metabolize drugs faster than
Asians.
 Laboratory animals can metabolize
drugs faster than man e.g. barbiturates.
DIET
The enzyme content and activity is altered
by a number of dietary components.
 Low protein diet decreases and high
protein content in diet increases the drug
metabolizing ability.
 Dietary deficiency of vitamins and
minerals retard the metabolic activity of
enzymes.
ALTERED PHYSIOLOGICAL
FACTORS
Pregnancy
Hormonal
Imbalance
Disease states
PREGNANCY
During pregnancy, metabolism of some
drugs is increased while that of others
is decreased due to the presence of
steroid hormones e.g.
 Phenytoin
 Phenobarbitone
 Pethidine
HORMONAL IMBALANCE
Higher levels of one hormone may inhibit the
activity of few enzymes while inducing that of
others. E.g.
 Hypothyroidism increases drug metabolizing
capacity (increased half life of
antipyrine, digoxin, methimazole, practolol)
while hyperthyroidism decreases it.
DISEASE STATES
Liver disease such as hepatic
carcinoma, cirrhosis, hepatitis, obstructive jaundice etc
reduce the hepatic drug metabolizing ability and thus
increase the half lives of almost all drugs.
In renal diseases conjugation of salycylates, oxidation of
vitamin D and hydrolysis of Procaine are impaired.
Cardiovascular diseases, although have no direct
effect, decrease the blood flow, which may slow
down biotransformation of drugs like
isoniazid, morphine and propanolol.
Pulmonary conditions may decrease biotransformation.
Procaine and procainamide hydrolysis is impaired.
TEMPORAL FACTOR
Diurnal variations and variations in enzyme activity
with light cycle is circadian rhythm.
Enzyme action is maximum during early morning
and minimum in late afternoon which is probably
due to high levels of coticosterone.
ROUTE OF ADMINISTRATION
Oral route can result in extensive hepatic metabolism of some
drugs (first pass effect).
Lignocaine is almost completely metabolized if taken by oral
route therefore the preferable route is Topical.
ENVIRONMENTAL FACTORS
 Aromatic hydrocarbon contained in Cigarette
smokers act as enzyme inducers.
 Chronic alcoholism might lead to enzyme induction
as well.
 Pesticides or Organophosphate insecticides may act
as enzyme inducers.
 In hot and humid climate biotransformation is
decreased and vice versa.
 At high altitude decreased biotransformation occurs
due to decreased oxygen leading to decreased
oxidation of drugs.
Factors affecting biotransformation of drugs
EAT A BIG BREAKFAST
AVERAGE LUNCH AND
A TINY DINNER
Factors affecting biotransformation of drugs

Mais conteúdo relacionado

Mais procurados

DRUG INTERACTIONS (MECHANISMS OF DRUG-DRUG INTERACTIONS)
DRUG INTERACTIONS (MECHANISMS OF DRUG-DRUG INTERACTIONS)DRUG INTERACTIONS (MECHANISMS OF DRUG-DRUG INTERACTIONS)
DRUG INTERACTIONS (MECHANISMS OF DRUG-DRUG INTERACTIONS)N Anusha
 
Biopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug AbsorptionBiopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug AbsorptionSURYAKANTVERMA2
 
Protein binding of drugs
Protein binding of drugsProtein binding of drugs
Protein binding of drugsNaresh Gorantla
 
Phase ii biotransform of drugs
Phase ii biotransform of drugsPhase ii biotransform of drugs
Phase ii biotransform of drugsRajat Mahamana
 
Pharmacokinetics: Excretion of drugs
Pharmacokinetics: Excretion of drugsPharmacokinetics: Excretion of drugs
Pharmacokinetics: Excretion of drugsFarazaJaved
 
Concept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretionConcept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretionchiranjibi68
 
BIOPHAMACEUICS- UNIT 1- DRUG ABSORPTION
BIOPHAMACEUICS- UNIT 1- DRUG ABSORPTIONBIOPHAMACEUICS- UNIT 1- DRUG ABSORPTION
BIOPHAMACEUICS- UNIT 1- DRUG ABSORPTIONKrutika Pardeshi
 
Factors affecting drug absorption
Factors affecting drug absorptionFactors affecting drug absorption
Factors affecting drug absorptionSURYAKANTVERMA2
 
Antineoplastic agents
Antineoplastic agentsAntineoplastic agents
Antineoplastic agentsRobin Gulati
 
Drug distribution
Drug distributionDrug distribution
Drug distributionNaser Tadvi
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kineticsSujit Patel
 
pharmacokinetic drug interactions
 pharmacokinetic drug interactions pharmacokinetic drug interactions
pharmacokinetic drug interactionsSyed Imran
 
Biopharmaceutical factors affecting metabolism
Biopharmaceutical factors affecting metabolismBiopharmaceutical factors affecting metabolism
Biopharmaceutical factors affecting metabolismSR drug laboratories
 
Sulphonamides (Sulfonamides) and Sulfones || B.Pharm VI Semester || Medicinal...
Sulphonamides (Sulfonamides) and Sulfones || B.Pharm VI Semester || Medicinal...Sulphonamides (Sulfonamides) and Sulfones || B.Pharm VI Semester || Medicinal...
Sulphonamides (Sulfonamides) and Sulfones || B.Pharm VI Semester || Medicinal...Mr.S.SEETARAM SWAMY
 
Protein drug binding
Protein drug bindingProtein drug binding
Protein drug bindingSagar Savale
 

Mais procurados (20)

DRUG INTERACTIONS (MECHANISMS OF DRUG-DRUG INTERACTIONS)
DRUG INTERACTIONS (MECHANISMS OF DRUG-DRUG INTERACTIONS)DRUG INTERACTIONS (MECHANISMS OF DRUG-DRUG INTERACTIONS)
DRUG INTERACTIONS (MECHANISMS OF DRUG-DRUG INTERACTIONS)
 
Biopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug AbsorptionBiopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug Absorption
 
ELIMINATION OF DRUGS BIOPHARMACEUTICS
ELIMINATION OF DRUGS BIOPHARMACEUTICSELIMINATION OF DRUGS BIOPHARMACEUTICS
ELIMINATION OF DRUGS BIOPHARMACEUTICS
 
Protein binding of drugs
Protein binding of drugsProtein binding of drugs
Protein binding of drugs
 
Phase ii biotransform of drugs
Phase ii biotransform of drugsPhase ii biotransform of drugs
Phase ii biotransform of drugs
 
Pharmacokinetics: Excretion of drugs
Pharmacokinetics: Excretion of drugsPharmacokinetics: Excretion of drugs
Pharmacokinetics: Excretion of drugs
 
Anthelmintic Drugs
Anthelmintic DrugsAnthelmintic Drugs
Anthelmintic Drugs
 
Bioavailability ppt
Bioavailability pptBioavailability ppt
Bioavailability ppt
 
Concept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretionConcept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretion
 
Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
 
BIOPHAMACEUICS- UNIT 1- DRUG ABSORPTION
BIOPHAMACEUICS- UNIT 1- DRUG ABSORPTIONBIOPHAMACEUICS- UNIT 1- DRUG ABSORPTION
BIOPHAMACEUICS- UNIT 1- DRUG ABSORPTION
 
Factors affecting drug absorption
Factors affecting drug absorptionFactors affecting drug absorption
Factors affecting drug absorption
 
Bioavailability
BioavailabilityBioavailability
Bioavailability
 
Antineoplastic agents
Antineoplastic agentsAntineoplastic agents
Antineoplastic agents
 
Drug distribution
Drug distributionDrug distribution
Drug distribution
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kinetics
 
pharmacokinetic drug interactions
 pharmacokinetic drug interactions pharmacokinetic drug interactions
pharmacokinetic drug interactions
 
Biopharmaceutical factors affecting metabolism
Biopharmaceutical factors affecting metabolismBiopharmaceutical factors affecting metabolism
Biopharmaceutical factors affecting metabolism
 
Sulphonamides (Sulfonamides) and Sulfones || B.Pharm VI Semester || Medicinal...
Sulphonamides (Sulfonamides) and Sulfones || B.Pharm VI Semester || Medicinal...Sulphonamides (Sulfonamides) and Sulfones || B.Pharm VI Semester || Medicinal...
Sulphonamides (Sulfonamides) and Sulfones || B.Pharm VI Semester || Medicinal...
 
Protein drug binding
Protein drug bindingProtein drug binding
Protein drug binding
 

Semelhante a Factors affecting biotransformation of drugs

Factors affecting biotransformation
Factors affecting biotransformationFactors affecting biotransformation
Factors affecting biotransformationMuhammad Usama
 
BIOTRANSFORMATION final ...pptx
BIOTRANSFORMATION final ...pptxBIOTRANSFORMATION final ...pptx
BIOTRANSFORMATION final ...pptxDipiyaSarkar
 
Drug interactions in dentistry
Drug interactions in dentistryDrug interactions in dentistry
Drug interactions in dentistryPGIDS,ROHTAK
 
Pharmacokinetics variations in Disease States.
Pharmacokinetics variations in Disease States.Pharmacokinetics variations in Disease States.
Pharmacokinetics variations in Disease States.Faizan Akram
 
5-Biotransformation and metabolism .pptx
5-Biotransformation and metabolism .pptx5-Biotransformation and metabolism .pptx
5-Biotransformation and metabolism .pptxbilaliqbal02
 
Inhibition and induction of drug metabolism
Inhibition and induction of drug metabolismInhibition and induction of drug metabolism
Inhibition and induction of drug metabolismDr. Ramesh Bhandari
 
Inhibition and induction of drug metabolism
Inhibition and induction of drug metabolismInhibition and induction of drug metabolism
Inhibition and induction of drug metabolismDr. Ramesh Bhandari
 
Pharmacology of Drugs interactions
 Pharmacology of Drugs interactions  Pharmacology of Drugs interactions
Pharmacology of Drugs interactions Manoj Kumar
 
Genetic polymorphism in drug metabolism
Genetic polymorphism in drug metabolismGenetic polymorphism in drug metabolism
Genetic polymorphism in drug metabolismM.Arumuga Vignesh
 
Drug Interactions ppt.pptx
Drug Interactions ppt.pptxDrug Interactions ppt.pptx
Drug Interactions ppt.pptxShikhaSachde
 
Drug interactions
Drug interactionsDrug interactions
Drug interactionsvelspharmd
 
Clinical-Relevance-of-Drug-Metabolism-part-2.pptx
Clinical-Relevance-of-Drug-Metabolism-part-2.pptxClinical-Relevance-of-Drug-Metabolism-part-2.pptx
Clinical-Relevance-of-Drug-Metabolism-part-2.pptxAlexLino17
 
druginteractions.pptx
druginteractions.pptxdruginteractions.pptx
druginteractions.pptxImtiyaz60
 
Individualization of dosage regimen
Individualization of dosage regimenIndividualization of dosage regimen
Individualization of dosage regimenPARUL UNIVERSITY
 
introduction_to_drug_interactions_pptx.pptx
introduction_to_drug_interactions_pptx.pptxintroduction_to_drug_interactions_pptx.pptx
introduction_to_drug_interactions_pptx.pptxHakeemUllah7
 
pharmacokinetic drug interaction and induction and inhibition of drug metabolism
pharmacokinetic drug interaction and induction and inhibition of drug metabolismpharmacokinetic drug interaction and induction and inhibition of drug metabolism
pharmacokinetic drug interaction and induction and inhibition of drug metabolismSUJITHA MARY
 

Semelhante a Factors affecting biotransformation of drugs (20)

Factors affecting biotransformation
Factors affecting biotransformationFactors affecting biotransformation
Factors affecting biotransformation
 
Drug interactions
Drug interactionsDrug interactions
Drug interactions
 
BIOTRANSFORMATION final ...pptx
BIOTRANSFORMATION final ...pptxBIOTRANSFORMATION final ...pptx
BIOTRANSFORMATION final ...pptx
 
Drug interactions in dentistry
Drug interactions in dentistryDrug interactions in dentistry
Drug interactions in dentistry
 
Pharmacokinetics variations in Disease States.
Pharmacokinetics variations in Disease States.Pharmacokinetics variations in Disease States.
Pharmacokinetics variations in Disease States.
 
5-Biotransformation and metabolism .pptx
5-Biotransformation and metabolism .pptx5-Biotransformation and metabolism .pptx
5-Biotransformation and metabolism .pptx
 
Inhibition and induction of drug metabolism
Inhibition and induction of drug metabolismInhibition and induction of drug metabolism
Inhibition and induction of drug metabolism
 
Inhibition and induction of drug metabolism
Inhibition and induction of drug metabolismInhibition and induction of drug metabolism
Inhibition and induction of drug metabolism
 
Pharmacology of Drugs interactions
 Pharmacology of Drugs interactions  Pharmacology of Drugs interactions
Pharmacology of Drugs interactions
 
Genetic polymorphism in drug metabolism
Genetic polymorphism in drug metabolismGenetic polymorphism in drug metabolism
Genetic polymorphism in drug metabolism
 
Nutrient drug interaction
Nutrient drug interactionNutrient drug interaction
Nutrient drug interaction
 
Drug metabolism affected by diseases
Drug metabolism affected by diseasesDrug metabolism affected by diseases
Drug metabolism affected by diseases
 
Drug Interactions ppt.pptx
Drug Interactions ppt.pptxDrug Interactions ppt.pptx
Drug Interactions ppt.pptx
 
Drug interactions
Drug interactionsDrug interactions
Drug interactions
 
Clinical-Relevance-of-Drug-Metabolism-part-2.pptx
Clinical-Relevance-of-Drug-Metabolism-part-2.pptxClinical-Relevance-of-Drug-Metabolism-part-2.pptx
Clinical-Relevance-of-Drug-Metabolism-part-2.pptx
 
Aditya gaederatric
Aditya gaederatricAditya gaederatric
Aditya gaederatric
 
druginteractions.pptx
druginteractions.pptxdruginteractions.pptx
druginteractions.pptx
 
Individualization of dosage regimen
Individualization of dosage regimenIndividualization of dosage regimen
Individualization of dosage regimen
 
introduction_to_drug_interactions_pptx.pptx
introduction_to_drug_interactions_pptx.pptxintroduction_to_drug_interactions_pptx.pptx
introduction_to_drug_interactions_pptx.pptx
 
pharmacokinetic drug interaction and induction and inhibition of drug metabolism
pharmacokinetic drug interaction and induction and inhibition of drug metabolismpharmacokinetic drug interaction and induction and inhibition of drug metabolism
pharmacokinetic drug interaction and induction and inhibition of drug metabolism
 

Último

pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfMedicoseAcademics
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptxWINCY THIRUMURUGAN
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaSujoy Dasgupta
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptPradnya Wadekar
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptxNIKITA BHUTE
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdfHongBiThi1
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu Medical University
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 

Último (20)

pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdf
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
 
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.ppt
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 

Factors affecting biotransformation of drugs

  • 2. TYPES OF FACTORS • Chemical • Biological • Altered Physiological • Temporal • Route of Drug Administration • Enviornmental
  • 3. Chemical Factors 1. Enzyme Induction 2. Enzyme Inhibition
  • 4. Enzyme Induction It is a process in which a drug induces or enhances the expression of an enzyme. Rifampicin If taken by female patients taking contraceptives, causes decreased therapeutic effect, leading to pregnancy. Phenobarbitone If administered to patients taking warfarin, may cause therapeutic failure, leading to increased bleeding tendency. Auto induction: The phenomenon in which a drug induces metabolism of other drugs as well as its own E.g. carbamazepine-antiepileptic.
  • 5. Enzyme Inhibition Decrease in the drug metabolizing ability of enzymes. Competition for the active sites takes place between the inhibitor and the drugs. When enzyme inhibitor attaches, less metabolism occurs. E.g.  Sulfonamides decrease the metabolism of phenytoin so that its blood levels become toxic.  Cimetidine decreases the metabolism of propanolol leading to enhanced bradycardia.  Oral contraceptives inhibit metabolism of antipyrine.
  • 7. AGE In infants microsomal enzyme system is not fully developed. The rate of metabolism is very low. Care should be taken in administering drugs in younger patients.  Chloramphenicol does not have great efficacy in infants. Toxic effects in the form of grey baby syndrome might occur. The baby may be cyanosed, hypothermic, flaccid and grey in color. Shock and even death might occur if toxic levels get accumulated.  Diazepam may result in floppy baby syndrome in which flaccidity of the baby is seen.
  • 8. AGE In elderly, most processes slow down which leads to decreased metabolism. Shrinkage of organs occurs as well along with decreased liver functions and decreased blood flow through the liver. All these factors decrease the metabolism. The drug doses should be decreased in the elderly
  • 9. GENDER Gender related differences in the rate of metabolism are attributed to sex hormones and are generally observed following puberty.  Male have a higher BMR as compared to the females, thus can metabolize drugs more efficiently, e.g. salicylates and others might include ethanol, propanolol, benzodiazepines.  Women on oral contraceptives metabolize drugs at a slower rate
  • 10. GENETICS Drugs behave differently in different individuals due to genetic variations Succinyl choline, which is a skeletal muscle relaxant, is metabolized by pseudocholine esterase. Some people lack this enzyme, due to which lack of metabolism of succinyl choline might occur. When administered in those individuals, prolonged Apnea might result. Different groups of populations might be classified as fast metabolizers and poor metabolizers of drugs. For drugs, like Isoniazid, fast acetylators as well as slow acetylators are present. Fast acetylators cause rapid acetylation, while poor metabolizers metabolize less. Hepatic acetyl transferrase catalyzes acetylation. Slow acetylation might occur due to genetic malformation leading to decreased production.
  • 11. RACE/SPECIES  Asians, Orientals, Blacks and Whites might have different drug metabolizing capacity. Examples include difference in drug metabolizing capacity of certain anti malarial.  Eskimos metabolize drugs faster than Asians.  Laboratory animals can metabolize drugs faster than man e.g. barbiturates.
  • 12. DIET The enzyme content and activity is altered by a number of dietary components.  Low protein diet decreases and high protein content in diet increases the drug metabolizing ability.  Dietary deficiency of vitamins and minerals retard the metabolic activity of enzymes.
  • 14. PREGNANCY During pregnancy, metabolism of some drugs is increased while that of others is decreased due to the presence of steroid hormones e.g.  Phenytoin  Phenobarbitone  Pethidine
  • 15. HORMONAL IMBALANCE Higher levels of one hormone may inhibit the activity of few enzymes while inducing that of others. E.g.  Hypothyroidism increases drug metabolizing capacity (increased half life of antipyrine, digoxin, methimazole, practolol) while hyperthyroidism decreases it.
  • 16. DISEASE STATES Liver disease such as hepatic carcinoma, cirrhosis, hepatitis, obstructive jaundice etc reduce the hepatic drug metabolizing ability and thus increase the half lives of almost all drugs. In renal diseases conjugation of salycylates, oxidation of vitamin D and hydrolysis of Procaine are impaired. Cardiovascular diseases, although have no direct effect, decrease the blood flow, which may slow down biotransformation of drugs like isoniazid, morphine and propanolol. Pulmonary conditions may decrease biotransformation. Procaine and procainamide hydrolysis is impaired.
  • 17. TEMPORAL FACTOR Diurnal variations and variations in enzyme activity with light cycle is circadian rhythm. Enzyme action is maximum during early morning and minimum in late afternoon which is probably due to high levels of coticosterone.
  • 18. ROUTE OF ADMINISTRATION Oral route can result in extensive hepatic metabolism of some drugs (first pass effect). Lignocaine is almost completely metabolized if taken by oral route therefore the preferable route is Topical.
  • 19. ENVIRONMENTAL FACTORS  Aromatic hydrocarbon contained in Cigarette smokers act as enzyme inducers.  Chronic alcoholism might lead to enzyme induction as well.  Pesticides or Organophosphate insecticides may act as enzyme inducers.  In hot and humid climate biotransformation is decreased and vice versa.  At high altitude decreased biotransformation occurs due to decreased oxygen leading to decreased oxidation of drugs.
  • 21. EAT A BIG BREAKFAST AVERAGE LUNCH AND A TINY DINNER